Академический Документы
Профессиональный Документы
Культура Документы
SCIENTIFIC PROGRAMME
SCIENTIFIC PROGRAMME
Chairman Panos Englezos (Cyprus) Co-Chairman, TIF President President of the Scientific Committee SESSION 1 EPIDEMIOLOGY & PREVENTION IN THE ASIAN AND SOUTH EAST ASIAN REGION Global epidemiology Specific reference to Asia Prevention and control programmes of haemoglobinopathies in Asia Ethical issues on prevention and management Beta-thalassaemia Genotype/Phenotype Epidemiology of alpha-thalassaemia and its importance in Asia Health systems: Asia Health systems: The Thai model Prevention of haemoglobinopathies in Malaysia Prevention of haemoglobinopathies in Southern China the Guangxi experience Clinical audit on the management of thalassaemia in a developing country Sri Lanka SESSION 2 BLOOD TRANSFUSION Blood transfusion: quality and safety issues in Thalassaemia: Current status New trends on blood transfusion safety Part I NAT testing New Trends in blood transfusion safety Part II Pathogen InactivationRBCs Thai Experience in blood safety issues SESSION 3 IRON CHELATION THERAPY Pathophysiology of iron overload Iron overload: consequences, assessment, and monitoring Iron chelation: treatment overview Update on survival in thalassaemia
SESSION 4 CARDIAC COMPLICATIONS Cardiac complications and advances in monitoring in thalassaemia major MRI in the assessment of cardiac iron overload The Thai experience SESSION 5 HbE SYNDROMES Epidemiology of HbE in Asia HbE/beta-thalassaemia: Genotype/Phenotype Diagnosis and management of alpha-thalassaemia HbH disease SESSION 6 ENDOCRINE COMPLICATIONS IN THALASSAEMIA Overview of endocrine complications in thalassaemia Growth Treatment of diabetes Pregnancy The burden of osteoporosis SESSION 7 INFECTIONS AND LIVER DISEASE IN THALASSAEMIA Overview of infections in thalassaemia in Asia Overview of liver disease in thalassaemia Overview of the prevailing of Hepatitis C and B virus infection in thalassaemia in Asia Treatment options and current therapy protocols in Asia Cost effectiveness SESSION 8 THALASSAEMIA INTERMEDIA Pathophysiology and complications of thalassaemia intermedia Overview and current status on treatment in thalassaemia intermedia
SESSION 9 STEM CELL TRANSPLANTATION Stem cell transplantation in developing countries BMT experience in Thailand BMT experience in China BMT experience in Pakistan the cost effective model BMT experience in India BMT experience in Vietnam SESSION 10 MOLECULAR THERAPEUTIC POTENTIALS Gene therapy: is it a reality? Fetal globin induction in -thalassaemia Copy drugs/counterfeit medicines effectiveness and safety SESSION 11 REFERENCE THALASSAEMIA CENTERS Requirements for a reference or expert thalassaemia centre. Copying the European efforts? Conference outcome Future Direction
CONFERENCE REGISTRATION FEES: MEDICAL DOCTORS: 100USD TRAINEE DOCTORS: 80USD LABORATORY SCIENTISTS: 50USD NURSES: 50 USD PATIENTS WITH THALASSAEMIA AND/OR PARENTS: FREE-OF-CHARGE
HOTEL ACCOMMODATION
3-STAR HOTEL 4-STAR HOTEL 5-STAR HOTEL 5-STAR HOTEL*** SINGLE ROOM IN USD 65 85 130 200 DOUBLE ROOM IN USD 65 95 140 220
* - ALL PRICES ON A BED AND BREAKFAST BASIS ** - ALL HOTEL RATES INDICATED ARE PRELIMINARY. THESE MAY CHANGE. *** - 5-STAR DELUXE HOTEL